Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|22|3457-3468

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.22, 2014-11, pp. : 3457-3468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the LKB1 Tumor Suppressor

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 32-52

Bentham Science Publishers

Access to resources Recommend Favorite

Gastroenteropancreatic high-grade neuroendocrine carcinoma

By Sorbye Halfdan   Strosberg Jonathan   Baudin Eric   Klimstra David S.   Yao James C.  

Cancer, Vol. 120, Iss. 18, 2014-09 ,pp. : 2814-2823

Blackwell Publishing

Access to resources Recommend Favorite

Inhibition of Ataxia Telangiectasia-p53-E2F-1 Pathway in Neurons as a Target for the Prevention of Neuronal Apoptosis

By  

Current Drug Metabolism, Vol. 8, Iss. 7, 2007-10 ,pp. : 709-715

Bentham Science Publishers

Access to resources Recommend Favorite

GLUT1 as a therapeutic target in hepatocellular carcinoma

By Amann Thomas   Hellerbrand Claus  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 12, 2009-12 ,pp. : 1411-1427

Informa Healthcare

Access to resources Recommend Favorite

p42.3 in Gastric Carcinoma: A Novel Biomarker and Promising Therapeutic Target

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 10, 2017-09 ,pp. : 1221-1225

Bentham Science Publishers

Access to resources Recommend Favorite